Elnair, Radowan A.
Holstein, Sarah A. https://orcid.org/0000-0002-9342-5635
Article History
Accepted: 26 March 2021
First Online: 19 April 2021
Declarations
:
: No external funding was used in the preparation of this manuscript.
: RAE declares that he has no conflicts of interest that might be relevant to the contents of this manuscript. SAH has served as a consultant for Bristol-Myers Squibb, Celgene, Genentech, GlaxoSmithKline, Oncopeptides, Sanofi, Sorrento, Takeda and has received research funding from Oncopeptides.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Both authors performed a literature review and wrote the manuscript.